Oral contraceptives and stroke

NEW YORK, July 6 (Praxis Press) Oral contraceptive (OC) use has been inconsistently associated with several adverse cardiovascular events. To assess whether OC use is associated with ischemic stroke, a recent study analyzed results of 16 observational studies identified in a review of the published literature from January 1960 through November 1999. Summary risk estimates indicated that current use of OCs, including newer low-estrogen preparations, was associated with a significantly increased r

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 6 (Praxis Press) Oral contraceptive (OC) use has been inconsistently associated with several adverse cardiovascular events. To assess whether OC use is associated with ischemic stroke, a recent study analyzed results of 16 observational studies identified in a review of the published literature from January 1960 through November 1999. Summary risk estimates indicated that current use of OCs, including newer low-estrogen preparations, was associated with a significantly increased risk of ischemic stroke, though the absolute risk is expected to be small since incidence in this population is low. Smaller estrogen doses were associated with a lower risk, but risk was significantly elevated for all dosages. The relative risk of stroke due to OC use was not different in women who smoked, had migraines, or hypertension.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform